Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
Table 3
Distribution of lipoprotein subfractions of the subjects according to the presence of insulin resistance.
Variables (%)
Total ()
Non-IR group ()
IR group ()
VLDL
17.85 (3.93)
16.80 (3.29)
18.42 (4.15)
0.017
IDL
28.64 (4.09)
29.08 (3.54)
28.39 (4.36)
0.277
LDL1
16.88 (3.99)
17.56 (3.61)
16.51 (4.16)
0.089
LDL2
9.84 (4.01)
8.84 (3.65)
10.39 (4.10)
0.013
LDL3
2.48 (2.75)
1.78 (2.00)
2.87 (3.02)
0.062
LDL4
0.42 (1.09)
0.28 (1.09)
0.50 (0.36)
0.063
LDL5
0.06 (0.40)
0.07 (0.46)
0.05 (0.36)
0.931
LDL6
0.01 (0.14)
0.03 (0.24)
0.00 (0.00)
0.176
LDL7
0.00 (0.00)
0.00 (0.00)
0.00 (0.00)
1.000
LDLLARGE
2.97 (3.83)
2.16 (3.20)
3.42 (4.07)
0.081
LDLSMALL
26.72 (4.81)
26.40 (4.92)
26.89 (4.77)
0.515
HDL1
10.66 (3.61)
11.00 (3.57)
10.47 (3.64)
0.346
HDL2
12.32 (4.36)
14.33 (4.15)
11.23 (4.08)
<0.001
HDL3
7.34 (2.11)
8.32 (2.08)
6.81 (1.94)
<0.001
HDL4
9.37 (1.60)
9.45 (1.39)
9.33 (1.70)
0.619
HDL5
11.06 (1.61)
10.58 (1.55)
11.32 (1.59)
0.003
HDL6
21.66 (3.01)
20.31 (2.76)
22.40 (2.88)
<0.001
HDL7
7.72 (1.43)
7.37 (1.33)
7.92 (1.45)
0.013
HDL8
7.64 (1.73)
7.23 (1.58)
7.87 (1.78)
0.017
HDL9
5.98 (1.77)
5.64 (1.61)
6.16 (1.83)
0.056
HDL10
6.22 (3.98)
5.75 (3.62)
6.48 (4.15)
0.239
HDLLARGE
30.32 (8.45)
33.64 (8.66)
28.51 (7.80)
<0.001
HDLINTERMEDIATE
49.81 (4.87)
47.72 (4.72)
50.95 (4.58)
<0.001
HDLSMALL
19.84 (6.50)
18.63 (6.10)
20.51 (6.64)
0.063
Data presented as mean (standard deviation). Comparative analysis was performed by Student’s t-tests or Mann–Whitney U test (). VLDL: very low-density lipoprotein; IDL: intermediate density lipoprotein; HDL: high-density lipoprotein; LDL: low-density lipoprotein; non-IR group: individuals without insulin resistance; IR group: individuals with insulin resistance.
